Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: Long-term results

Gastrointestinal Endoscopy

Volumn 58, Issue 2, 2003, Pages 183-188

  Overholt, Bergein F ^a,b   Panjehpour, Masoud ^a   Halberg, Daniel L ^a  

^a PC ^*

^b Gastrointestinal Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; OMEPRAZOLE; PHOTOFRIN; ANTIULCER AGENT;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER SURVIVAL; DYSPLASIA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; ADENOCARCINOMA; ESOPHAGUS TUMOR; METAPLASIA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; PRECANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; MALE; METAPLASIA; MIDDLE AGED; OMEPRAZOLE; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS;

EID: 0347065374     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2003.327     Document Type: Article

References (28)

1. Sampliner RE. Ablative therapies for the columnar-lined esophagus. Gastroenterol Clin North Am 1997;26:685-94.
2. van den Boogert J, van Hillegersberg R, Siersema PD, de Bruin RW, Tilanus HW. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol 1999;94:1153-60.
3. Haag S, Nandurkar S, Talley N. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc 1999;50:229-40.
4. Fisher AM, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med 1995;17:2-31.
5. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-56.
6. Overholt BF, Panjehpour M, Haydek J. Photodynamic therapy for Barrett's esophagus: follow up in 100 patients. Gastrointest Endosc 1999;49:1-7.
7. Panjehpour M, Overholt BF, Haydek JM, Lee SG. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 2000;95:2177-84.
8. Wang KK. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am 2000;10:409-19.
9. Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-55.
10. Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC, Krasner N. Eradication of high grade dysplasia in columnar lined (Barrett's) esophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584-5.
11. Panjehpour M, Overholt BF, Haydek JM. Light sources and delivery devices for gastrointestinal photodynamic therapy. Gastrointest Endosc Clin N Am 2000;10:513-32.
12. Overholt BF, Panjehpour M. Photodynamic therapy techniques for ablation of Barrett's esophagus. Techniques in Gastrointest Endosc 2000;2:203-8.
13. Kleinbaum DG. Survival analysis: a self-learning text. New York: Spring-Verlag; 1996.
14. StatSoft, Inc. STATISTICA for Windows. Tulsa (OK): StatSoft; 1998.
15. Mantel N. Ranking procedures for arbitrarily restricted observations. Biometrics 1967;23:65-78.
16. Loh CS, Vernon D, MacRobert AJ, Bedwell J, Bown SG, Brown SB. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J Photochem Photobiol 1993;20:47-54.
17. van den Boogert J, Houtsmuller AB, de Rooij FW, de Bruin RW, Siersema PD, van Hillegersberg R. Kinetics, localization and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus. Lasers Surg Med 1999;24:3-13.
18. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
19. Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
20. Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000;95:1888-93.
21. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50.
22. Schnell TG, Sontag SJ, Cheifec G, Aranha A, Metz A, O'Connell S, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120:1607-19.
23. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
24. Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Theisen J, Peters JH, Kiyabu M. Occult esophageal adenocarcinoma: extent of disease and implications for effective therapy. Ann Surg 1999;230:433-40.
25. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
26. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992;54:199-204.
27. Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-9.
28. Quato-Lascar R, Fitzgerald RC, Triadiafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999;117:327-35.